Dennis Yiannakis

568 total citations
16 papers, 208 citations indexed

About

Dennis Yiannakis is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dennis Yiannakis has authored 16 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dennis Yiannakis's work include Endometrial and Cervical Cancer Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Dennis Yiannakis is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Dennis Yiannakis collaborates with scholars based in United Kingdom, Japan and Germany. Dennis Yiannakis's co-authors include Graham Sewell, Awadhesh N. Jha, Leonie Eastlake, Po Dunn, Joseph Mathew, MJ Seckl, T. Gulliford, Penny Johnson, N.J.F. Dodd and Iain Lindsay and has published in prestigious journals such as Human Reproduction, BJOG An International Journal of Obstetrics & Gynaecology and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Dennis Yiannakis

15 papers receiving 204 citations

Peers

Countries citing papers authored by Dennis Yiannakis

Since Specialization

Citations

This map shows the geographic impact of Dennis Yiannakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Yiannakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Yiannakis more than expected).

Fields of papers citing papers by Dennis Yiannakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Yiannakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Yiannakis. The network helps show where Dennis Yiannakis may publish in the future.

Co-authorship network of co-authors of Dennis Yiannakis

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Yiannakis. A scholar is included among the top collaborators of Dennis Yiannakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Yiannakis. Dennis Yiannakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic 2022 ·Obstetrical & Gynecological Survey ·(unknown), Sudha Sundar, Rebecca Bowen, (unknown), (unknown), Christina Fotopoulou, Sadaf Ghaem‐Maghami, Jonathan A. Ledermann, Ranjit Manchanda, (unknown), Agnieszka Michael, Tracie Miles, Shibani Nicum, Andrew Nordin, B. Ramsay, Stuart Rundle, Sarah Williams, Nicholas Wood, Dennis Yiannakis, Jo Morrison	1
2	A single centre evaluation of the 2019 UK SABR consortium guidelines for primary lung cancer: correlation between Prescription Dose Spillage and inverse Paddick Conformity Index 2022 ·Reports of Practical Oncology & Radiotherapy ·(unknown), (unknown), Rachel Norris, Dennis Yiannakis	0
3	British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic 2021 ·International Journal of Gynecological Cancer ·Alexandra Taylor, Sudha Sundar, Rebecca Bowen, (unknown), (unknown), Christina Fotopoulou, Sadaf Ghaem‐Maghami, Jonathan A. Ledermann, Ranjit Manchanda, (unknown), Agnieszka Michael, Tracie Miles, Shibani Nicum, Andrew Nordin, B. Ramsay, Stuart Rundle, Sarah Williams, Nicholas Wood, Dennis Yiannakis, Jo Morrison	2
4	Insufficiency Fractures in Postmenopausal Gynaecological Patients Receiving Pelvic Radiotherapy: Can These be Prevented by Optimisation of Bone Health? 2019 ·Clinical Oncology ·Leonie Eastlake, (unknown), Dennis Yiannakis	2
5	Insufficiency fractures in postmenopausal gynaecological patients receiving pelvic radiotherapy treatment – can we prevent them by optimising bone health? 2019 ·Clinical Medicine ·Leonie Eastlake, (unknown), (unknown), Glenn Matfin, (unknown), Dennis Yiannakis	1
6	Niraparib as maintenance therapy in a patient with ovarian cancer and brain metastases 2019 ·BMJ Case Reports ·(unknown), (unknown), Dennis Yiannakis	20
7	EGFR targeted therapy in lung cancer; an evolving story 2017 ·Respiratory Medicine Case Reports ·(unknown), Leonie Eastlake, Po Dunn, Dennis Yiannakis	27
8	Linking genotoxicity and cytotoxicity with membrane fluidity: A comparative study in ovarian cancer cell lines following exposure to auranofin 2016 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·(unknown), N.J.F. Dodd, Dennis Yiannakis, Rana Moyeed, Awadhesh N. Jha	10
9	BRCA1 deficiency increases the sensitivity of ovarian cancer cells to auranofin 2015 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·(unknown), Dennis Yiannakis, Awadhesh N. Jha	23
10	Unilateral Optic Disc Papilloedema following Administration of Carboplatin Chemotherapy for Ovarian Carcinoma 2014 ·Case Reports in Oncology ·(unknown), Salman Waqar, Dennis Yiannakis, (unknown)	8
11	Occupational exposure to anti-cancer drugs: A review of effects of new technology 2013 ·Journal of Oncology Pharmacy Practice ·(unknown), Dennis Yiannakis, (unknown), Graham Sewell	54
12	Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC) 2009 ·BMC Cancer ·Sharon Glaysher, Dennis Yiannakis, Francis G Gabriel, Penny Johnson, Marta E. Polak, Louise A. Knight, (unknown), (unknown), (unknown), Paul Modi, (unknown), Mark E. Smith, Khalid Amer, Bruce Addis, Matthew Poole, Ajit Narayanan, T. Gulliford, Peter E. Andreotti, Ian A. Cree	33
13	Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma 2007 ·Anti-Cancer Drugs ·Ioannis Gounaris, (unknown), (unknown), (unknown), Bruce Lyons, Dennis Yiannakis	6
14	Nongestational choriocarcinoma arising from a primary ovarian tumour 2007 ·BJOG An International Journal of Obstetrics & Gynaecology ·(unknown), Joseph Mathew, (unknown), Iain Lindsay, Rosemary A. Fisher, MJ Seckl, Dennis Yiannakis	14
15	The role of ultrasonographically guided puncture of the human rete testis in the therapeutic management of nonobstructive azoospermia* 2003 ·Andrologia ·Apostolos Kaponis, Dennis Yiannakis, (unknown), (unknown), (unknown), D. Baltogiannis, X Giannakopoulos, M. Schrader, Ioannis Georgiou, Yasuhisa Yamamoto, N. Kanakas, Ikuo Miyagawa, D. Loutradis, (unknown), Nikolaos Sofikitis	6
16	Meiosis and Klinefelter's syndrome 2002 ·Human Reproduction ·N. Sofikitis, Dennis Yiannakis, Anthoula Chatzikyriakidou, (unknown), (unknown), (unknown), Ioannis Georgiou, M. Schrader, Yasuhisa Yamamoto, Ikuo Miyagawa, X Giannakopoulos	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact